These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17459668)

  • 1. Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence.
    Falagas ME; Giannopoulou KP; Ntziora F; Papagelopoulos PJ
    Int J Antimicrob Agents; 2007 Sep; 30(3):202-9. PubMed ID: 17459668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daptomycin in bone and joint infections: a review of the literature.
    Rice DA; Mendez-Vigo L
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic treatment of gram-positive bone and joint infections.
    Darley ES; MacGowan AP
    J Antimicrob Chemother; 2004 Jun; 53(6):928-35. PubMed ID: 15117932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections.
    Finney MS; Crank CW; Segreti J
    Curr Med Res Opin; 2005 Dec; 21(12):1923-6. PubMed ID: 16368041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate oral antibiotics for bone and joint infections based on the susceptibility of clinical Staphylococcus aureus isolates.
    Lee CS; Hwang JH; Lee JH; Song SK; Cho JH; Lee JH
    Korean J Intern Med; 2015 Mar; 30(2):262-4. PubMed ID: 25750572
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of cSSTIs: the role of daptomycin.
    Garau J
    Curr Med Res Opin; 2006 Nov; 22(11):2079-87. PubMed ID: 17076967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin to bone and joint infections and prosthesis joint infections: a systematic review.
    Telles JP; Cieslinski J; Tuon FF
    Braz J Infect Dis; 2019; 23(3):191-196. PubMed ID: 31207214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage therapy for complex bone and joint infections with ceftaroline: a multicentre, observational study.
    Malandain D; Dinh A; Ferry T; Touchais S; Lustig S; Laurent F; Corvec S; Bémer P; Asseray N; Boutoille D
    Int J Antimicrob Agents; 2017 Aug; 50(2):277-280. PubMed ID: 28689872
    [No Abstract]   [Full Text] [Related]  

  • 9. Tigecycline option for the treatment of bone and joint infections caused by multidrug-resistant Staphylococcus epidermidis.
    Asseray N; Bemer P; Corvec S; Boutoille D; Touchais S; Navas D
    Joint Bone Spine; 2012 Jan; 79(1):97-9. PubMed ID: 21816648
    [No Abstract]   [Full Text] [Related]  

  • 10. Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections.
    Frippiat F; Meunier F; Derue G
    J Antimicrob Chemother; 2004 Dec; 54(6):1158; author reply 1159. PubMed ID: 15498877
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vancomycin therapy in bone and joint infections--looking into the future].
    Krasin E; Goldwirth M; Otremski I
    Harefuah; 2000 Jun; 138(11):994-6. PubMed ID: 10979416
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis.
    Kullar R; McClellan I; Geriak M; Sakoulas G
    Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adequate use of teicoplanin in bone and joint infections].
    Senneville E; Legout L; Corroyer B; Yazdanpanah Y; Mouton Y
    Med Mal Infect; 2004 Jun; 34 Suppl 1():S99-102. PubMed ID: 15676260
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral versus intravenous antibiotic treatment for bone and joint infections (OVIVA): study protocol for a randomised controlled trial.
    Li HK; Scarborough M; Zambellas R; Cooper C; Rombach I; Walker AS; Lipsky BA; Briggs A; Seaton A; Atkins B; Woodhouse A; Berendt A; Byren I; Angus B; Pandit H; Stubbs D; McNally M; Thwaites G; Bejon P
    Trials; 2015 Dec; 16():583. PubMed ID: 26690812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service.
    Mackintosh CL; White HA; Seaton RA
    J Antimicrob Chemother; 2011 Feb; 66(2):408-15. PubMed ID: 21118914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combination.
    Legout L; Senneville E; Stern R; Yazdanpanah Y; Savage C; Roussel-Delvalez M; Rosele B; Migaud H; Mouton Y
    Clin Microbiol Infect; 2006 Oct; 12(10):1030-3. PubMed ID: 16961643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Challenges in the antimicrobial treatment of infective endocarditis. Role of daptomycin].
    Almirante B; Miró JM
    Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():26-32. PubMed ID: 22541972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful clinical use of daptomycin-impregnated bone cement in two-stage revision hip surgery for prosthetic joint infection.
    Cortes NJ; Lloyd JM; Koziol L; O'Hara L
    Ann Pharmacother; 2013 Jan; 47(1):e2. PubMed ID: 23324502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin resistance in prosthetic joint infections.
    Sivakumar B; Vijaysegaran P; Chaudhuri A; Crawford S; Ottley M
    Orthopedics; 2012 Apr; 35(4):e603-6. PubMed ID: 22495870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.